Showing results (371-380 of 1,039) with videos related to

Sort By:
Pageof 104
The Journal of Surgical Research|February 25, 2021
Angiotensin-Converting Enzyme Inhibitor/Receptor Blocker, Diuretic, or Nonsteroidal Anti-inflammatory Drug Use After Major Surgery and Acute Kidney Injury: A Case-Control StudyDerek J Roberts, Stephen A Smith, Zhi Tan, et al.
Kidney International|August 6, 2010
Acute kidney injury following coronary angiography is associated with a long-term decline in kidney functionMatthew T James, William A Ghali, Marcello Tonelli, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 24, 2010
Modeling survival of arteriovenous accesses for hemodialysis: semiparametric versus parametric methodsPietro Ravani, Patrick Parfrey, Jennifer MacRae, et al.
BMC Medical Research Methodology|March 3, 2011
Validation of a case definition to define chronic dialysis using outpatient administrative dataFiona M Clement, Matthew T James, Rick Chin, et al.
The Cochrane Database of Systematic Reviews|February 28, 2020
Pharmacological interventions for heart failure in people with chronic kidney diseaseMeaghan Lunney, Marinella Ruospo, Patrizia Natale, et al.
Lancet (London, England)|September 19, 2003
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trialJohn J V McMurray, Jan Ostergren, Karl Swedberg, et al.
Lancet (London, England)|September 19, 2003
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved TrialSalim Yusuf, Marc A Pfeffer, Karl Swedberg, et al.
Circulation|August 25, 2010
Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapyScott D Solomon, Elyse Foster, Mikhail Bourgoun, et al.
Lancet (London, England)|September 19, 2003
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trialChristopher B Granger, John J V McMurray, Salim Yusuf, et al.
American Heart Journal|August 23, 2006
Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trialAndrew G Bostom, Myra A Carpenter, John W Kusek, et al.
Pageof 104